America Great Health (AAGH)
America Great Health is a U.S.-based biotechnology company whose common stock is listed on OTC Markets under the symbol AAGH. The company focuses on research and development in protein and peptide small-molecule drugs, while also working on the manufacture and sale of AI cloud computing-based diagnostic and medical devices, cell therapy products, regenerative medicine, and nutritional dietary supplements. It was previously known as Crown Marketing and adopted the America Great Health name in March 2017. The company is based in Alhambra, California.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Altman Z-Score | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
OTC-AAGH
|
$0.00020
|
-33.3% Downside
|
Overvalued
|
Not available
|
Not available
|
Fair
|
0.0%
|
October 13, 2026
|
6.6x
|
11.6x
|
6.346 M
|
8.497 M
|
51.4%
|
-105.8
|
-55.2%
|